Posted by Clinical Lab Products | Feb 12, 2005 | Cancer, Miscellaneous |
By George Hollenberg, MD In an age when insurance mandates and HMO rules and regulations are as much a part of the practice of medicine as stethoscopes and prescription pads, it is no surprise that our choices as physicians have become more const
Read MorePosted by Clinical Lab Products | Feb 11, 2005 | Miscellaneous |
AAB Scores Victory in NY Laboratory Fees Dispute According to the American Association of Bioanalysts(AAB), every year the New York Department of Health charges laboratories holding New York State laboratory permits several millions of dollars for
Read MorePosted by Clinical Lab Products | Feb 2, 2005 | Clinical Chemistry, Clinical Chemistry Analyzers, Clinical Chemistry Test Kits, Miscellaneous |
By Nicholas Borgert Buoyed by the premise that faster testing and diagnoses translate into improved patient care, hospitals continue to invest in and utilize new point-of-care testing (POCT) products. This is done after weighing overall costs, co
Read MorePosted by Clinical Lab Products | Jan 11, 2005 | Cancer, Miscellaneous |
Henry Ford Health System to Serve as Test Site for Imaging Products Trestle Holdings has announced an agreement with Michigan-based Henry Ford Health System (HFHS) in which Trestle will work with HFHS to implement and integrate pathology digital i
Read MorePosted by Clinical Lab Products | Jan 10, 2005 | Cancer, Miscellaneous |
Inverness Medical Innovations Inc and its subsidiary Wampole Laboratories LLC, manufacturer and marketer of rapid diagnostic products for the consumer and professional markets, has announced the availability of a new immunoassay fecal occult blood
Read More